Does the imprecise definition of overactive bladder serve commercial rather than patient interests?

Eur Urol. 2012 Apr;61(4):746-8; discussion 749-50. doi: 10.1016/j.eururo.2011.12.013. Epub 2012 Jan 5.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anticholesteremic Agents / therapeutic use
  • Conflict of Interest
  • Drug Industry / ethics
  • Evidence-Based Medicine
  • Humans
  • Terminology as Topic*
  • Unnecessary Procedures
  • Urinary Bladder / drug effects
  • Urinary Bladder / physiopathology*
  • Urinary Bladder, Overactive / classification*
  • Urinary Bladder, Overactive / diagnosis
  • Urinary Bladder, Overactive / drug therapy
  • Urinary Bladder, Overactive / physiopathology

Substances

  • Anticholesteremic Agents